Intuitive Surgical posts Q4 beat, shares down on lowering profit margin guide
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/8/2026
- Fiserv president resigns, interim leaders named for financial unit
- Nasdaq sinks as AI worries hit chipmakers
- Amazon launches bond sale seeking at least $25 billion
- Raymond James Starts SpaceX (SPCX) at Strong Buy, PT Street High $800
- Exclusive-China's DeepSeek developing its own AI chip, sources say
Intuitive Surgical (ISRG) PT Raised to $666 at Truist Securities
January 24, 2025 5:34 AM ESTTruist Securities analyst Richard Newitter raised the price target on Intuitive Surgical (NASDAQ: ISRG) to $666.00 (from $640.00) while maintaining a Buy rating.
The analyst comments "ISRG saw big 4Q EPS upside on a rev beat that was preannounced on 1/15. The... More
Intuitive Surgical (ISRG) PT Raised to $585 at Deutsche Bank
January 24, 2025 5:30 AM ESTDeutsche Bank analyst Imron Zafar raised the price target on Intuitive Surgical (NASDAQ: ISRG) to $585.00 (from $505.00) while maintaining a Hold rating.
The analyst comments "4Q procedure growth remained quite healthy and 2025 guidance points to the sustainability of these strong utilization trends which ultimately drive the entire... More
Intuitive Surgical (ISRG) PT Raised to $622 at BTIG
January 24, 2025 5:27 AM ESTBTIG analyst Ryan Zimmerman raised the price target on Intuitive Surgical (NASDAQ: ISRG) to $622.00 (from $561.00) while maintaining a Buy rating.
The analyst comments "We maintain our Buy and raise our PT to $622 (from $561 PT) following 4Q24 results. ISRG reported revenue of $2.414B (25% Y/Y) and... More
Intuitive Surgical (ISRG) PT Raised to $688 at Raymond James
January 24, 2025 5:24 AM ESTRaymond James analyst Jayson Bedford raised the price target on Intuitive Surgical (NASDAQ: ISRG) to $688.00 (from $560.00) while maintaining a Outperform rating.
The analyst comments "The 4Q EPS upside was even bigger than most investors were thinking, on stronger margins (at 38%). While the... More

